APA (7th ed.) Citation

Zhao, N., You, W., Zheng, X., Yan, J., Wang, P., Yao, Y., . . . Liu, T. (2025). Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma. Elsevier.

Chicago Style (17th ed.) Citation

Zhao, Ni, Weiming You, Xiaoqiang Zheng, Jin Yan, Peili Wang, Yu Yao, Wangxiao He, and Tianya Liu. Dual-targeted N-PMIplus@CA Nanoplatform for Concurrent MDM2 and β-catenin Inhibition in P53 Wild-type Lung Adenocarcinoma. Elsevier, 2025.

MLA (9th ed.) Citation

Zhao, Ni, et al. Dual-targeted N-PMIplus@CA Nanoplatform for Concurrent MDM2 and β-catenin Inhibition in P53 Wild-type Lung Adenocarcinoma. Elsevier, 2025.